Clinical Trials List
2013-03-18 - 2013-12-06
Phase II
Terminated8
-
Trial Applicant
TaiGen Biotechnology Co., Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/19
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 陳威廷 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Po-Chang Lin Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 湯宏仁 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 陳永哲 Division of Thoracic Medicine
- 蘇茂昌 Division of Thoracic Medicine
- 方文豐 Division of Thoracic Medicine
- 王逸熙 Division of Thoracic Medicine
- 陳泓丞 Division of Thoracic Medicine
- Chia-Cheng Tseng Division of Thoracic Medicine
- 秦建弘 Division of Thoracic Medicine
- 劉世豐 Division of Thoracic Medicine
- 黃國棟 Division of Thoracic Medicine
- 梁深怡 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
11 participants
-
Global
207 participants
